Agile Therapeutics, Inc. (AGRX)
OTCMKTS: AGRX · Delayed Price · USD
0.380
+0.010 (2.70%)
Apr 19, 2024, 3:44 PM EDT - Market closed

Agile Therapeutics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Year 2023202220212020201920182017201620152014 2013 - 2012
Net Income
-14.47-25.41-76.59-54.69-18.44-19.78-28.3-28.74-30.34-16.08
Upgrade
Depreciation & Amortization
0.391.532.220.280.160.020.020.020.020.01
Upgrade
Share-Based Compensation
1.982.493.342.821.763.633.653.432.971.38
Upgrade
Other Operating Activities
2.52-14.565.824.280.83-0.770.0721.870.18
Upgrade
Operating Cash Flow
-9.58-35.95-65.2-47.31-15.69-16.9-24.56-23.3-25.48-14.5
Upgrade
Capital Expenditures
0-0.13-0.27-0.35-0.1-0.32-1.31-0.03-0.29-0.1
Upgrade
Acquisitions
0000.35000000
Upgrade
Change in Investments
---39.73-69.34------
Upgrade
Other Investing Activities
--79.4628.65------
Upgrade
Investing Cash Flow
0-0.1339.46-40.69-0.1-0.32-1.31-0.03-0.29-0.1
Upgrade
Common Stock Issued
8.2435.4330.3548.4342.25018.5437.5319.3349.74
Upgrade
Other Financing Activities
-1.35-13.250.0819.550.16-10.89-5.460.160.652.92
Upgrade
Financing Cash Flow
6.8922.1830.4267.9942.42-10.8913.0837.6919.9852.66
Upgrade
Net Cash Flow
-2.69-13.94.68-20.0226.63-28.1-12.814.36-5.7938.06
Upgrade
Free Cash Flow
-9.58-36.08-65.47-47.66-15.79-17.21-25.87-23.33-25.77-14.6
Upgrade
Free Cash Flow Margin
-48.88%-331.50%-1596.46%-6363.68%------
Upgrade
Free Cash Flow Per Share
-0.00-83.48-53956.18-1125.72-638.74-1003.26-1672.46-1650.54-2340.84-2562.48
Upgrade
Sources: The data provider is Financial Modeling Prep and the numbers are sourced from SEC filings.